Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 8, 2024
RNS Number : 1669G Stifel Nicolaus Europe Limited 08 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Form 8.3 - Renalytix Plc

March 8, 2024
RNS Number : 1754G Harwood Capital LLP 08 March 2024     FORM 8.3     PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser:

Polar Capital Hldgs - Form 8.3 - RENALYTIX PLC

March 6, 2024
RNS Number : 8935F Polar Capital Holdings PLC 06 March 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 6, 2024
RNS Number : 8156F Stifel Nicolaus Europe Limited 06 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Form 8.3 - Renalytix Plc

March 5, 2024
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.            KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 5, 2024
RNS Number : 6301F Stifel Nicolaus Europe Limited 05 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Unicorn Asset Mgmt. - Form 8.3 - Renalytix plc

March 4, 2024
RNS Number : 5092F Unicorn Asset Management Limited 04 March 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of

Approach from Possible Strategic Acquiror

March 4, 2024
RNS Number : 4140F Renalytix PLC 04 March 2024   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

Grant of Share Options - replacement

March 1, 2024
RNS Number : 3507F Renalytix PLC 01 March 2024   The following amendment has been made to the ' Grant of Share Options ' announcement released on 23 November 2023 at 07:00 under RNS No 3917U .   The sentence " All the Share Options granted one twelfth of the Share Options vest 3 months from the

US Government coverage expanded

February 29, 2024
RNS Number : 9346E Renalytix PLC 29 February 2024     THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF MAR. THE PERSON RESPONSIBLE FOR ARRANGING THE RELEASE OF THIS ANNOUNCEMENT ON BEHALF OF RENALYTIX IS JAMES MCCULLOUGH , CEO.   Renalytix plc ("Renalytix" or the "Company")
Displaying 61 - 70 of 353